外基因介导的circRNA Hsa_Circ_0113050通过与EIF4A3相互作用,增强结肠直肠癌细胞恶性
1Department of Pain Treatment/Hepatobiliary Surgery/Vascular Surgery/Gastrointestinal Surgery, Affiliated Hospital of Jianghan University (The Sixth Hospital of Wuhan), Wuhan, China.
DNA and cell biology
|July 14, 2025
概括
携带圆形RNA hsa_circ_0113050的外基因组促进结直肠癌 (CRC) 的生长和扩散. 这种循环RNA与EIF4A3相互作用,为CRC治疗提供了一个潜在的新点.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- 循环RNAs (circRNAs) 与癌症的发展有关.
- 外基因组促进细胞间通信,并可以运输功能分子,如circRNAs.
- 在结直肠癌 (CRC) 中外体介导circRNAs的特定作用需要进一步阐明.
研究的目的:
- 为了研究外体介导circRNA hsa_circ_0113050在结直肠癌 (CRC) 中的作用.
- 在CRC中探索hsa_circ_0113050和真核细胞翻译启动因子4A3 (EIF4A3) 之间的相互作用.
- 评估hsa_circ_0113050作为CRC的治疗点的潜力.
主要方法:
- 使用超离心,传输电子显微镜和纳米粒子追踪分析,对CRC衍生的外体进行隔离和表征.
- 通过生物信息分析和qRT-PCR对CRC组织和外体中的hsa_circ_0113050表达的量化.
- 功能性试验 (基于细胞和体内) 来评估外体和hsa_circ_0113050对CRC细胞恶性病变的影响.
- 通过RNA免疫沉,西式涂抹和qRT-PCR进行hsa_circ_0113050-EIF4A3相互作用的分析.
主要成果:
- 来自CRC的外体 (102-104nm) 显著增强了CRC细胞的增殖,迁移和入侵.
- hsa_circ_0113050在CRC组织和外体细胞中被上调.
- 在外体内静止hsa_circ_0113050扭转了亲恶性瘤效应.
- 发现EIF4A3与hsa_circ_0113050 (EIF3I) 的线性前体结合,从而促进hsa_circ_0113050在CRC细胞中的表达.
结论:
- 外基因介导的hsa_circ_0113050通过与EIF4A3.3的相互作用促进结直肠癌细胞恶性病变.
- 这项研究阐明了CRC中circRNA调节的新型机制.
- 外体 hsa_circ_0113050 是结直肠癌的一个有前途的治疗点.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K


